
Refaber 550mg Tablet
Marketer
Berbrick Healthcare Pvt Ltd
Salt Composition
Rifaximin (550mg)
Overview Refaber 550mg Tablet
Hepatic encephalopathy, a liver-related condition causing toxic buildup in the bloodstream and subsequent brain damage, is treated with the antibiotic Refaber 550mg tablets. This medication also combats infectious diarrhea. Its mechanism involves eliminating and inhibiting the proliferation of harmful intestinal bacteria. Refaber 550mg may be administered independently or alongside other medications, with or without food, ideally at a consistent time daily. Dosage and treatment duration should strictly adhere to your physician's instructions; consistent daily intake maximizes efficacy. Premature cessation can result in infection recurrence and treatment complications. Potential side effects, including nausea, vomiting, headache, dizziness, rashes, arthralgia, and depression, are generally transient and resolve as the body adapts. Persistent or bothersome side effects necessitate medical consultation. A harmless, temporary reddish discoloration of urine is a possible consequence. Prior to commencing Refaber 550mg therapy, inform your doctor of any existing liver, kidney, or heart conditions, pregnancy, breastfeeding, or drug allergies.
Primary Ingredients of Refaber 550mg Tablet
The information is unavailable.
Uses of Refaber 550mg Tablet
Managing hepatic encephalopathy and infectious diarrhea.
Major Benefits of Refaber 550mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 550mg Refaber Tablet whole; do not alter its form. It can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Refaber 550mg Tablet:
- Dizziness
- Nausea
- Peripheral edema
- Ascites (accumulation of fluid in the abdominal cavity)
- Fatigue
- Depression
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Joint pain
- Rash
- Muscle pain
How to use Refaber 550mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Refaber 550mg Tablets can be consumed with or without food; however, consistent daily timing is recommended.
How Refaber 550mg Tablet works:
Ammonium-reducing bacteria in the gut are targeted by the antibiotic Refaber 550mg Tablet. This action combats infection and alleviates hepatic encephalopathy symptoms (including restlessness, disorientation, and neuromuscular issues). The medication also helps prevent future hepatic encephalopathy occurrences.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Refaber 550mg Tablet lacks established safety data. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Refaber 550mg Tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Using Refaber 550mg tablets while breastfeeding is likely safe. Available data from human studies indicate minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Refaber 550mg Tablets.
KidneySAFE IF PRESCRIBED
For individuals with kidney disease, Refaber 550mg tablets are likely safe. Available evidence indicates dose modification may be unnecessary, but physician consultation is recommended.
LiverCAUTION
Individuals with advanced liver impairment should exercise caution when using Refaber 550mg tablets. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Refaber 550mg Tablet :
Should you forget a Refaber 550mg Tablet dose, ingest it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual regimen. Avoid taking a double dose.
Facts to Know About Refaber 550mg Tablet
| Label | Value |
|---|---|
| Type of Compound | Rifamycin-based antibiotics |
| Potential for Dependence | None. |
| Type of Treatment | Digestive system |
| Mechanism of Action | Rifamycin antibiotics, which target RNA polymerase. |
